{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T08:21:38Z","timestamp":1700295698302},"reference-count":22,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2006,7,20]],"date-time":"2006-07-20T00:00:00Z","timestamp":1153353600000},"content-version":"vor","delay-in-days":10062,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med. Pediatr. Oncol."],"published-print":{"date-parts":[[1979,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A combination regimen consisting of cisplatin, bleomycin, and vinblastine was evaluated in 86 patients with metastatic testicular tumors. Prior therapy included surgical resection of primary tumor (84 patients), radiotherapy (21 patients), chemotherapy (33 patients). Thirteen patients received prior bleomycin and vincristine or vinblastine. Of 80 evaluable patients 51 achieved complete response (CR) and 26 achieved partial response (PR), for an overall response rate 96.5%. There was no significant difference in response rates or survival with respect to prior therapy, sites of metastatic lesions, and tumor histology. The median survival time was not reached in an observation period of 44+ months. Sixty patients were alive 11+\u201344+ months, and 57 of these were free of disease. Thirty\u2010two of the 60 patients (53%) had a survival time greater than 20 months. Toxicities included nephrotoxicity (18 patients) leukopenia, (69 patients), thrombocytopenia (nine patients), and anemia (56 patients). Bleomycin\u2010induced pulmonary toxicity was fatal in one patient. Other toxicities included nausea and vomiting, stomatitis, fever, alopecia, and neurological effects.<\/jats:p>","DOI":"10.1002\/mpo.2950060303","type":"journal-article","created":{"date-parts":[[2007,2,20]],"date-time":"2007-02-20T14:56:01Z","timestamp":1171983361000},"page":"195-205","source":"Crossref","is-referenced-by-count":8,"title":["Cisplatin, bleomycin, and vinblastine combination therapy of testicular tumors: An analysis"],"prefix":"10.1002","volume":"6","author":[{"given":"Joan C.","family":"D'aoust","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archie W.","family":"Prestayko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lawrence H.","family":"Einhorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert L.","family":"Comis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra J.","family":"Ginsberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. A. T.","family":"Archambault","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley T.","family":"Crooke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,7,20]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"429","article-title":"Treatment of metastatic testicular carcinoma with bleomycin used alone or in combination with CCNU","volume":"59","author":"Sonntag RW","year":"1975","journal-title":"Cancer Chemother Rep"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197304)31:4<903::AID-CNCR2820310422>3.0.CO;2-N"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-86-6-803"},{"key":"e_1_2_1_5_2","first-page":"563","article-title":"Continuous intravenous bleomycin therapy with vinblastine in State III testicular neoplasia","volume":"59","author":"Samuels ML","year":"1975","journal-title":"Cancer Chemother Rep"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197508)36:2<318::AID-CNCR2820360205>3.0.CO;2-V"},{"key":"e_1_2_1_7_2","first-page":"213","article-title":"Vinblastine and bleomycin therapy for disseminated testicular tumors","volume":"58","author":"Spigel SC","year":"1974","journal-title":"Cancer Chemother Rep"},{"key":"e_1_2_1_8_2","first-page":"98","article-title":"Intermittent versus continuous infusion bleomycin in testicular cancer: A comparison of response and survival in embyronal carcinoma (class 2) and teratocarcinoma (class 3 and 4)","volume":"17","author":"Samuels ML","year":"1976","journal-title":"Proc Am Assoc Cancer Res"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0305-7372(76)80009-6"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197602)37:2<637::AID-CNCR2820370205>3.0.CO;2-M"},{"key":"e_1_2_1_11_2","first-page":"232","article-title":"Germ cell tumors chemotherapy update","volume":"18","author":"Cvitkovic E","year":"1977","journal-title":"Proc Am Soc Clin Oncol"},{"key":"e_1_2_1_12_2","unstructured":"GolbeyRB: Personal communication. Cited in: Cisplatin New Drug Application Amendment vol 2.1 p90 1978."},{"key":"e_1_2_1_13_2","first-page":"754","article-title":"Erste therapeutische, erfahrungen mit cisplatinum II diammedichlorid bei metastasierandem ovarund hoden Karzinomen","volume":"106","author":"Cavalli F","year":"1976","journal-title":"Schweiz Med Wochenschr"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197405)33:5<1219::AID-CNCR2820330505>3.0.CO;2-U"},{"key":"e_1_2_1_15_2","first-page":"243","article-title":"A new method to prevent toxicity with doses of cis diamine platinum (therapeutic efficacy in previously untreated widespread and recurrent testicular tumors)","volume":"17","author":"Merrin C","year":"1976","journal-title":"Proc Am Soc Clin Oncol"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0028-1104058"},{"key":"e_1_2_1_17_2","unstructured":"ChengE CvitkovicE WittesRE GolbeyRB: Germ cell tumors (II): VAB II in metastatic testicular cancer.Cancer(in press)."},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-87-3-293"},{"key":"e_1_2_1_19_2","first-page":"308","article-title":"Combination chemotherapy of disseminated testicular carcinoma with cis\u2010diamine\u2010dichloroplatinum, vinblastine, and bleomycin (PVB); an update","volume":"19","author":"Einhorn LH","year":"1978","journal-title":"Proc Am Soc Clin Oncol"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(195305)6:3<427::AID-CNCR2820060302>3.0.CO;2-U"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/0010-4809(77)90006-4"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950050115"},{"key":"e_1_2_1_23_2","first-page":"202","volume-title":"Testicular Tumors","author":"Samuels ML","year":"1976"}],"container-title":["Medical and Pediatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fmpo.2950060303","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/mpo.2950060303","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,12]],"date-time":"2023-11-12T23:03:52Z","timestamp":1699830232000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/mpo.2950060303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1979,1]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1979,1]]}},"alternative-id":["10.1002\/mpo.2950060303"],"URL":"https:\/\/doi.org\/10.1002\/mpo.2950060303","archive":["Portico"],"relation":{},"ISSN":["0098-1532","1096-911X"],"issn-type":[{"value":"0098-1532","type":"print"},{"value":"1096-911X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1979,1]]}}}